Q1 Clinical trials round-up: Jan-Mar 2025
The first quarter of 2025 saw a wave of significant advancements in clinical research across oncology, neurology, dermatology, respiratory, and rare diseases.
Navigating the complexities of drug development in hepatolog...
In the realm of medical research, liver disease remains a complex and often overlooked field.
Digital support reduces GLP-1 dose needed for weight loss
Combining weight-loss drugs with online patient support can achieve results that match the drugs given on their own, but with a much-reduced dose.
Bayer CEO confident firm can cope with Xarelto hit
Bayer's CEO says new product launches will offset the decline in sales of anticoagulant Xarelto over the course of 2025.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
Operationalize: Expanded Access Programs comes to the West C...
Improving Global Access to Life-Changing Therapeutics...
Injectable Drug Delivery 2025 – Driving Innovation Through C...
Press Release: Injectable Drug Delivery 2025 – Driving Innovation Through Collaboration LONDON, UK – 24–25 June 2025
4th In Vivo Cell Engineering & Gene Editing Summit
This forum brings together the brightest minds from biopharma, academia, and regulatory leadership to explore the full translational journey
6th Gene Therapy Analytical Development Summit Europe
Join 24+ expert speakers and over 90 industry stakeholders to unlock analytical strategies that elevate your development programmes,...
6th RNA Editing Summit | July 29-31, 2025 | Advance RNA Edit...
The 6th RNA Editing Summit returns to Boston this July, bringing together 60+ experts to propel the next generation of RNA editing therapies